JUN 17, 2020 9:47 PM PDT

Treating Atherosclerosis

WRITTEN BY: Nouran Amin

The two main proponents for atherosclerotic plaque and inflammation is an increase in cholesterol and macrophage presence in the arteries. Researchers at KAIST discuss that there designed physicochemical cargo-switching nanoparticles (CSNP) can address these issues.

What is atherosclerosis? A chronic inflammatory condition that targets the vasculature and characterized by the cholesterol and macrophage accumulation forming plaques in the arteries. If the atherosclerosis condition worsens, it may lead to heart attacks and strokes and potentially death.

Using the CSNP therapy, two drugs can be delivered at the same time. These drugs, cyclodextrin and statin, were proven to promote cholesterol-lowering, anti-inflammatory, and anti-proliferative functions. The therapeutic partnership of cyclodextrin and statin resolves the inflammatory environment of atherosclerosis.

"While nanomedicine has been mainly developed for the treatment of cancers, our studies show that nanomedicine can also play a significant role in treating and preventing atherosclerosis, which causes various cardiovascular diseases that are the leading causes of death worldwide, adds Professor Ji-Ho Park from KAIST’s Department of Bio and Brain Engineering.

Source: Science Daily

About the Author
  • Nouran is a scientist, educator, and life-long learner with a passion for making science more communicable. When not busy in the lab isolating blood macrophages, she enjoys writing on various STEM topics.
You May Also Like
OCT 07, 2021
Drug Discovery & Development
Extended approval for a drug to treat children living with HIV
OCT 07, 2021
Extended approval for a drug to treat children living with HIV
On Monday October 4th, ViiV Healthcare announced that it had submitted an application to the United States Food and Drug ...
OCT 21, 2021
Drug Discovery & Development
Cholesterol Drug Regrows Neurons After Spinal Cord Injury
OCT 21, 2021
Cholesterol Drug Regrows Neurons After Spinal Cord Injury
Fenofibrate, an FDA-approved drug used to reduce cholesterol levels, causes sensory neurons in the spine following spina ...
OCT 21, 2021
Cannabis Sciences
Cannabis as a Prospective Treatment for Fibromyalgia? - Emerging Evidence
OCT 21, 2021
Cannabis as a Prospective Treatment for Fibromyalgia? - Emerging Evidence
Fibromyalgia is a common disease impacting millions of adults in the United States. The condition can be extremely debil ...
OCT 28, 2021
Cannabis Sciences
What do Student Doctors and Medical Professionals Think of Cannabis?
OCT 28, 2021
What do Student Doctors and Medical Professionals Think of Cannabis?
In the current environment the legalization of cannabis, and its use for medicinal purposes, has been a divisive topic o ...
NOV 03, 2021
Plants & Animals
A Samoan Plant May Reduce Inflammation as Well as Ibuprofen
NOV 03, 2021
A Samoan Plant May Reduce Inflammation as Well as Ibuprofen
To the people of Samoa, the medicinal qualities of a tree known as matalafi are well known. Now scientists are bringing ...
NOV 25, 2021
Immunology
Battling Bacterial Pneumonia, No Antibiotics Required
NOV 25, 2021
Battling Bacterial Pneumonia, No Antibiotics Required
Instead of flooding the body with antibiotics, what if we could program cells to fight off pathogens more effectively? T ...
Loading Comments...